- Home
- OLMA vs SNEX Comparison
OLMA vs SNEX Comparison
Compare OLMA & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OLMA | SNEX |
|---|---|---|
| Founded | 2006 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 4.9B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | OLMA | SNEX |
|---|---|---|
| Price | $24.64 | $101.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $40.50 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 334.5K |
| Earning Date | 11-10-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.92 |
| EPS | N/A | ★ 5.89 |
| Revenue | N/A | ★ $130,897,700,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.74 |
| P/E Ratio | ★ N/A | $17.38 |
| Revenue Growth | N/A | ★ 32.62 |
| 52 Week Low | $2.86 | $64.42 |
| 52 Week High | $36.26 | $106.98 |
Technical Indicators
Market Signals| Indicator | OLMA | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 62.86 |
| Support Level | $24.45 | $94.70 |
| Resistance Level | $36.26 | $100.62 |
| Average True Range (ATR) | 1.99 | 3.01 |
| MACD | -1.15 | 0.31 |
| Stochastic Oscillator | 5.64 | 100.00 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.